Position in RVTY
as of Jun 30, 2026
· filed Jul 14, 2026
Position Value
$301,180
+$47,812 QoQ
Shares Held
2,707
-6.4% QoQ
Ownership
0.002%
of shares outstanding
% of Portfolio
0.12%
of 13F equity value
Holder Rank
#331
of 538 holders
Holding Since
Sep 2024
8 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in RVTY Over Time
Shares Held
Position Value (USD)
Position in Diagnostics & Research
Healthcare · as of Jun 30, 2026Net Worth Advisory Group holds $3,377,385 across 7 Diagnostics & Research names. RVTY ranks #5 (8.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | DGX |
Quest Diagnostics Inc
|
4,833 | $1,024,354 | |
| 2 | DHR |
Danaher Corp /De/
|
3,382 | $644,203 | |
| 3 | NTRA |
Natera, Inc.
|
1,994 | $541,271 | |
| 4 | ICLR |
Icon PLC
|
2,389 | $414,993 | |
| 5 | RVTY |
Revvity, Inc.
This page
|
2,707 | $301,180 | |
| 6 | ADPT |
Adaptive Biotechnologies Corp
|
2,733 | $234,491 | |
| 7 | IDXX |
Idexx Laboratories Inc /De
|
412 | $216,893 |
All Filings in RVTY
Export CSV
8 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $301,180 | 2,707 | Shares | Sole | 2026-07-14 | |
| 2026-03-31 | $253,368 | 2,892 | Shares | Sole | 2026-05-05 | |
| 2025-12-31 | $319,178 | 3,299 | Shares | Sole | 2026-01-14 | |
| 2025-09-30 | $291,611 | 3,327 | Shares | Sole | 2025-10-15 | |
| 2025-06-30 | $291,030 | 3,009 | Shares | Sole | 2025-07-22 | |
| 2025-03-31 | $307,878 | 2,910 | Shares | Sole | 2025-04-15 | |
| 2024-12-31 | $313,177 | 2,806 | Shares | Sole | 2025-02-07 | |
| 2024-09-30 | $356,678 | 2,792 | Shares | Sole | 2024-10-17 | |
| No filing history on record for this holder in this stock. | ||||||